Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AMGN – Amgen Inc.

Float Short %

2.33

Margin Of Safety %

10

Put/Call OI Ratio

0.93

EPS Next Q Diff

-0.85

EPS Last/This Y

13.43

EPS This/Next Y

0.63

Price

293.5

Target Price

310.33

Analyst Recom

2.35

Performance Q

8.03

Relative Volume

0.69

Beta

0.48

Ticker: AMGN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25AMGN306.660.900.39128886
2025-07-28AMGN301.220.901.03125383
2025-07-29AMGN303.570.890.84128538
2025-07-30AMGN301.370.910.92130096
2025-07-31AMGN295.020.910.51131390
2025-08-01AMGN296.810.900.79132587
2025-08-04AMGN302.40.920.60127956
2025-08-05AMGN294.850.900.92131478
2025-08-06AMGN284.70.930.96143058
2025-08-07AMGN284.680.900.67147852
2025-08-08AMGN288.320.880.69148490
2025-08-11AMGN285.650.940.36133011
2025-08-12AMGN284.790.930.32134020
2025-08-13AMGN288.770.920.92135023
2025-08-14AMGN289.860.930.47136694
2025-08-15AMGN296.490.920.33139392
2025-08-18AMGN292.981.120.32111187
2025-08-19AMGN295.511.080.09114377
2025-08-20AMGN296.380.980.30120610
2025-08-21AMGN295.930.980.04121626
2025-08-22AMGN293.720.930.48126139
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25AMGN306.585.85808.920.85
2025-07-28AMGN301.106.05670.720.87
2025-07-29AMGN303.566.15976.320.88
2025-07-30AMGN301.376.15799.420.88
2025-07-31AMGN295.106.15636.420.88
2025-08-01AMGN296.886.15957.920.88
2025-08-04AMGN301.946.26089.820.88
2025-08-05AMGN300.086.25812.420.88
2025-08-06AMGN284.756.25302.020.88
2025-08-07AMGN284.706.25877.320.88
2025-08-08AMGN288.23-8.05172.520.97
2025-08-11AMGN285.05-8.04897.720.97
2025-08-12AMGN284.93-8.15020.721.04
2025-08-13AMGN289.33-8.15206.121.04
2025-08-14AMGN290.21-8.15063.021.04
2025-08-15AMGN296.48-8.05278.221.05
2025-08-18AMGN292.60-8.04873.021.05
2025-08-19AMGN295.55-8.15145.321.06
2025-08-20AMGN296.39-8.15060.821.06
2025-08-21AMGN295.75-8.44999.421.05
2025-08-22AMGN293.50-8.44936.921.05
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25AMGN-6.813.602.74
2025-07-28AMGN-6.813.192.74
2025-07-29AMGN-6.813.192.74
2025-07-30AMGN-6.813.192.74
2025-07-31AMGN-6.813.192.74
2025-08-01AMGN-6.813.192.74
2025-08-04AMGN-6.813.152.74
2025-08-05AMGN-6.813.152.74
2025-08-06AMGN-6.813.152.74
2025-08-07AMGN-6.693.152.74
2025-08-08AMGN-6.693.152.74
2025-08-11AMGN-4.713.122.74
2025-08-12AMGN-4.713.122.33
2025-08-13AMGN-4.713.122.33
2025-08-14AMGN-4.013.122.33
2025-08-15AMGN-4.013.122.33
2025-08-18AMGN-4.012.892.33
2025-08-19AMGN-4.202.892.33
2025-08-20AMGN-4.202.892.33
2025-08-21AMGN-4.022.892.33
2025-08-22AMGN-0.232.892.33
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

6.02

Avg. EPS Est. Current Quarter

5.11

Avg. EPS Est. Next Quarter

5.17

Insider Transactions

-0.23

Institutional Transactions

2.89

Beta

0.48

Average Sales Estimate Current Quarter

9002

Average Sales Estimate Next Quarter

9373

Fair Value

324.22

Quality Score

86

Growth Score

91

Sentiment Score

93

Actual DrawDown %

15.4

Max Drawdown 5-Year %

-24.9

Target Price

310.33

P/E

24.03

Forward P/E

13.55

PEG

5.59

P/S

4.55

P/B

21.29

P/Free Cash Flow

14.91

EPS

12.22

Average EPS Est. Cur. Y​

21.05

EPS Next Y. (Est.)

21.68

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.04

Relative Volume

0.69

Return on Equity vs Sector %

64.4

Return on Equity vs Industry %

56

EPS 1 7Days Diff

EPS 1 30Days Diff

0.21

EBIT Estimation

4936.9
Amgen Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 28000
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
stock quote shares AMGN – Amgen Inc. Stock Price stock today
news today AMGN – Amgen Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AMGN – Amgen Inc. yahoo finance google finance
stock history AMGN – Amgen Inc. invest stock market
stock prices AMGN premarket after hours
ticker AMGN fair value insiders trading